Adlai Nortye Group (ANL) vs Obsidian Therapeutics (OBX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 17, 2026.
Summary
Obsidian Therapeutics is the larger company by market cap ($727.1 million vs $710.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANL | OBX |
|---|---|---|
| Share price | $11.03 | $11.77 |
| Market cap | $710.31M | $727.07M |
| 1-day change | -8.77% | -3.52% |
| YTD return | +676.76% | — |
| 1-year return | +572.56% | — |
| EPS (TTM) | $-0.66 | $-1.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-51.87M | — |
| 52-week high | $17.25 | $49.97 |
| 52-week low | $0.879 | $11.62 |
| Distance from 52-week high | -36.06% | -76.45% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +167.45% | +231.35% |
| Average volume | 212.90K | 366.70K |
| Shares outstanding | 58.73M | 61.77M |
| Employees | 109 | 87 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Adlai Nortye Group
ANL stock →Adlai Nortye Group Ltd., a clinical-stage biopharmaceutical company, engages in the discovery and development of cancer therapies. The company's pipeline centers on RAS-targeting therapies and next-generation cancer immunotherapies.
Health Care · Biotechnology: Pharmaceutical Preparations · 109 employees
About Obsidian Therapeutics
OBX stock →Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies.
Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees
ANL vs OBX FAQ
Which is bigger, Adlai Nortye Group or Obsidian Therapeutics?
Obsidian Therapeutics (OBX) is larger, with a market capitalization of $727.07M compared with $710.31M for Adlai Nortye Group (ANL).
Are Adlai Nortye Group and Obsidian Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.